tyrosine and Central Nervous System Neoplasms

tyrosine has been researched along with Central Nervous System Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bison, B; Buck, AK; Dierks, A; Eyrich, M; Frühwald, MC; Kertels, O; Kircher, M; Krauß, J; Lapa, C; Mihovilovic, MI; Monoranu, CM; Pham, M; Samnick, S; Schlegel, PG1
Bohner, G; Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Siebert, E1
Hansen, PB; Nielsen, SL; Pedersen, MØ; Penkowa, M1
Deckert, M; Haake, A; Montesinos-Rongen, M; Pellissery, S; Richter, J; Siebert, R1
Blain, SW; Ciznadija, D; Hukkelhoven, E; Koff, A; Liu, Y; Yeh, N1
Cho, H; Hong, J; Im, KS; Jung, JH; Kim, DK; Lee, CO; Liu, Y; Park, Y1

Other Studies

6 other study(ies) available for tyrosine and Central Nervous System Neoplasms

ArticleYear
[
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:6

    Topics: Adolescent; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Decision-Making; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult

2023
Quantitative biparametric analysis of hybrid
    Scientific reports, 2019, 10-10, Volume: 9, Issue:1

    Topics: Adult; Area Under Curve; Brain Neoplasms; Central Nervous System Neoplasms; False Positive Reactions; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Treatment Outcome; Tyrosine

2019
Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain; Cell Cycle Proteins; Cell Proliferation; Central Nervous System Neoplasms; DNA-Binding Proteins; Guanine; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Low Density Lipoprotein Receptor-Related Protein-2; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Malondialdehyde; Metallothionein; Middle Aged; Minichromosome Maintenance Complex Component 7; Nuclear Proteins; Oxidative Stress; Tyrosine

2010
Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:11

    Topics: Biopsy; Cell Line, Tumor; Central Nervous System Neoplasms; DNA Mutational Analysis; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Frequency; Humans; Lymphoma; Mutation, Missense; Polycomb Repressive Complex 2; Transcription Factors; Tyrosine

2010
Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma.
    The Journal of biological chemistry, 2012, Nov-09, Volume: 287, Issue:46

    Topics: Amino Acid Sequence; Animals; Cell Proliferation; Central Nervous System Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; HEK293 Cells; Humans; Mice; Molecular Sequence Data; Mutation; Phosphorylation; Tyrosine

2012
New bromotyrosine derivatives from an association of two sponges, Jaspis wondoensis and Poecillastra wondoensis.
    Journal of natural products, 2003, Volume: 66, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Central Nervous System Neoplasms; Colonic Neoplasms; Disulfides; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Humans; Korea; Lung Neoplasms; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Ovarian Neoplasms; Porifera; Skin Neoplasms; Staphylococcus; Tumor Cells, Cultured; Tyrosine

2003